Wockhardt receives US FDA approval
Wockhardt, a global pharmaceutical company headquartered in Mumbai in India announced that it has received final approval from the US Food and Drug Administration (USFDA) to market (on prescription basis) Amiodarone Hydrochloride.
The said drug would be available in the injection form in the strength of 50 mg/ml.
Amiodarone Hydrochloride is a medicine which is used in heart rhythm.
Recently, the company received a final approval from USFDA to market (on prescription basis) Risperidone drug, used in Psychiatric Medicine to treat cases of Schizophrenia, a form of insanity.
November 06, 2008